Literature DB >> 24463306

Changes in psychiatric comorbidity during early postsurgical period in patients operated for medically refractory epilepsy--a MINI-based follow-up study.

Soaham Desai1, Garima Shukla2, Vinay Goyal3, Achal Srivastava3, M V Padma Srivastava3, Manjari Tripathi3, Mamta Singh3, K Shivanand4, Rajesh Sagar4, Aditya Gupta5, P Saratchandra5, Ajay Garg6, C S Bal7, Madhuri Behari3.   

Abstract

PURPOSE: The purpose of this study was to assess axis-I DSM-IV psychiatric disorders in patients at baseline and 3 months after surgery for medically refractory temporal lobe epilepsy.
METHOD: The Mini International Neuropsychiatric Interview (MINI) and Quality of Life in Epilepsy Inventory-10 (QOLIE-10) were evaluated before and 3 months after surgery in 50 consecutive patients (21 females, 29 males) with medically refractory temporal lobe epilepsy (persistent seizures>2/month, despite treatment with ≥2 appropriate drugs in adequate doses for ≥2 years) who underwent surgery [anterior temporal lobectomy with amygdalo-hippocampectomy (for mesial temporal sclerosis in 40), electrocorticography-guided lesionectomy (for other lesions in 10)].
RESULTS: Twenty-six patients (52%) had an axis-I psychiatric disorder [26% depressive disorder, 28% anxiety disorder] at baseline, while 30 (60%) patients had an axis-I psychiatric disorder [28% depressive disorder, 28% anxiety disorder] at 3 months after surgery. Twenty percent developed a new psychiatric disorder, while 12% showed improvement postsurgery. Mean QOLIE-10 scores improved from 23.78 to 17.80 [24 (48%) patients showed ≥5-point improvement]. Thirty-four (68%) patients had no seizure, 6 (12%) had non-disabling seizures, while 2 (4%) had disabling seizures after surgery. High frequency of seizures prior to surgery (p<0.038) and seizure occurrence after surgery (p<0.055) predicted the presence of psychiatric disorders after surgery. No clinical characteristic could predict development of new psychiatric disorder after surgery.
CONCLUSION: Psychiatric dysfunction in the early postsurgery period is seen in nearly half of patients undergoing surgery for temporal lobe epilepsy, is mild in nature, and does not adversely affect quality of life but may cause significant clinical problems when it arises de novo postsurgery.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epilepsy surgery; Outcome; Psychiatric comorbidity

Mesh:

Year:  2014        PMID: 24463306     DOI: 10.1016/j.yebeh.2013.11.025

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

1.  Survey on Smoking, Consuming Alcohol, and using Illicit Drugs in Patients with Epilepsy.

Authors:  Naz Yeni; Feray Tumay; Özge Tonguç; Elvin Azaroğlu; Naz Bozok
Journal:  Noro Psikiyatr Ars       Date:  2015-12-01       Impact factor: 1.339

2.  An interaction network of mental disorder proteins in neural stem cells.

Authors:  M J Moen; H H H Adams; J H Brandsma; D H W Dekkers; U Akinci; S Karkampouna; M Quevedo; C E M Kockx; Z Ozgür; W F J van IJcken; J Demmers; R A Poot
Journal:  Transl Psychiatry       Date:  2017-04-04       Impact factor: 6.222

3.  High Frequency of Depressive Symptoms among Adults with Epilepsy: Results from a Hospital-based Study.

Authors:  Syam C Chandrasekharan; Vikas Menon; Vaibhav Wadwekar; Pradeep Pankajakshan Nair
Journal:  J Neurosci Rural Pract       Date:  2017-08

4.  Psychiatric Residue of Epilepsy Surgery: De Novo or Not.

Authors:  Jay Salpekar
Journal:  Epilepsy Curr       Date:  2019-06-13       Impact factor: 7.500

5.  Does antiepileptic drug withdrawal predispose patients undergoing temporal lobe epilepsy surgery to late onset of psychiatric morbidity? A report of three cases.

Authors:  Garima Shukla; Priya Agarwal; Rajesh Sagar; Mamta Sood; Aditya Gupta; Ashish Suri; Ajay Garg
Journal:  Ann Indian Acad Neurol       Date:  2016 Jul-Sep       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.